Omalizumab and the immune system: an overview of preclinical and clinical data-Reference-Cited by-同舟云学术

Omalizumab and the immune system: an overview of preclinical and clinical data

Published:2002-08 Issue:2 Volume:89 Page:132-138
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Johansson S.G.O.,Haahtela Tari,O'Byrne Paul M.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference61 articles.

1. Physico-chemical properties of reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity;Ishizaka;J Immunol,1966

2. Immunological studies of an atypical (myeloma) immunoglobulin;Johansson;Immunology,1967

3. Immunoglobulin E. A new class of human immunoglobulin;Bennich;Bull World Health Org,1968

4. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force;Johansson;Allergy,2001

5. The human IgE network;Sutton;Nature,1993

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omalizumab in severe asthma and food allergies with IgE levels >1500 kU/L: Two‐year evaluation;Pediatric Allergy and Immunology;2023-12

2. Omalizumab: a quarter of a century in the fight against T2-inflammatory diseases of upper and lower respiratory tract;Meditsinskiy sovet = Medical Council;2023-11-16

3. 抗IgE抗体（オマリズマブ）;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2023-08-20

4. Characterization and pre-clinical assessment of a proposed biosimilar to its originator Omalizumab;European Journal of Pharmaceutical Sciences;2022-11

5. Severe pediatric asthma with a poor response to omalizumab: a report of three cases and three-dimensional bronchial wall analysis;Journal of International Medical Research;2022-01